Physician profile
Mitchell E Fingerman
NPI 1326258435
$228,733.40
in general payments reported to CMS, 2019-2025
4 companies · $36K in 2025
The $36K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45K · 2020: $24K · 2021: $47K · 2022: $34K · 2023: $15K · 2024: $27K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $69K · Travel and Lodging: $8,527 · Food and Beverage: $784 · Consulting Fee: $46.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $69,405.70 |
| Travel and Lodging | $8,526.97 |
| Food and Beverage | $783.67 |
| Consulting Fee | $46.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $226,843.51 | 2019-2025 | On-Q, On-Q* Pump and Accessories, On-Q Pump and Accessories |
| Heron Therapeutics, INC. | $1,799.47 | 2022-2023 | Aponvie |
| Mindray Ds USA, INC. | $56.70 | 2021 | |
| Merck Sharp & Dohme LLC | $33.72 | 2023-2024 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Fingerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.